A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapy
Y. Zhang(Sichuan University), Xiangrong Song(Sichuan University), Zhongshan He(University of Virginia), Zhuanzhuan Lv(Sichuan University), Shugang Qin(Sichuan University), Siyu Zhao(Sichuan University), Guang Xie(Sichuan University), Tingting Song(Shenzhen Bay Laboratory), Zhiying Huang(Third Affiliated Hospital of Guangzhou Medical University), Haixing Shi(Sichuan University), Yu‐Ting Chen(National Taiwan University), Yang Zhao(Beijing Proteome Research Center), Min Sun(Sichuan University), Ruyue Liu(Sichuan University), Yinghan Zhang(Sichuan University), Hai Huang(Xi'an Shiyou University)
Cited by 7
Related Papers
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics
|Signal Transduction and Targeted Therapy|2022|1.3k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
mRNA-based therapeutics: powerful and versatile tools to combat diseases
|Signal Transduction and Targeted Therapy|2022|710
Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment
|Nature Nanotechnology|2024|148